Engineered human liver tissue is revealing new insights into the mechanisms that allow colorectal cancer cells to lie dormant, potentially for years, before reactivating and forming metastases. Researchers at the University of Michigan have developed a sophisticated 3D scaffold mimicking the liver environment, allowing them to observe this process in a controlled laboratory setting.
The study, published recently, focuses on the phenomenon of cancer dormancy – a state where cancer cells remain viable but do not actively proliferate. This dormancy is a major hurdle in effective cancer treatment, as these cells are often resistant to conventional therapies. The liver is a common site for colorectal cancer to metastasize, and understanding how cancer cells establish and maintain dormancy within this organ is crucial.
The engineered liver scaffolds, constructed from extracellular matrix components, provide a more realistic microenvironment than traditional 2D cell cultures. This allows researchers to observe how colorectal cancer cells interact with liver cells, known as hepatocytes, and respond to various signaling molecules. The research demonstrates that hepatocytes can induce dormancy in colorectal cancer cells, but this dormancy isn’t permanent.
A key finding centers on the role of the inflammatory cytokine IL-8, also known as CXCL8. According to research published in Nature, IL-8 appears to promote the escape of cancer cells from this hepatocyte-induced dormancy. The presence of IL-8 disrupts the signals that retain the cancer cells in a quiescent state, allowing them to resume growth and potentially spread. Researchers observed that increased IL-8 signaling correlated with the reactivation of cancer cells within the liver scaffold.
The use of hydrogel microenvironments, as explored in parallel research published by Science | AAAS, offers another avenue for studying cancer cell behavior. These hydrogels can be tailored to mimic the physical and biochemical properties of the tumor microenvironment, providing a platform for drug screening and investigating the factors that influence cancer cell growth and dormancy. While the Michigan study focuses specifically on the liver, the broader application of hydrogel technology underscores the growing trend toward more physiologically relevant in vitro cancer models.
Similar research, detailed in Nature, has also demonstrated spontaneous dormancy in metastatic breast cancer cells within a human liver microphysiologic system. This reinforces the idea that the liver environment itself plays a significant role in regulating cancer cell fate, independent of the specific cancer type. The convergence of these findings highlights the importance of the liver as a sanctuary for dormant cancer cells.
The University of Michigan team is now investigating potential therapeutic strategies to target IL-8 signaling and prevent cancer cells from escaping dormancy. Further research will focus on identifying the specific molecular mechanisms that regulate this process and developing drugs that can effectively disrupt the reactivation of dormant cancer cells. The team has not yet announced a timeline for potential clinical trials.
